Archive
All news, publications, and updates from Seek Labs.
Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™ October 7, 2025 BioSeeker mapped more than 10,000 isolates and identified targetable regions that provide 100% strain coverage across the viral family. Early in vitro testing of the BioSeeker-developed therapeutic construct achieved up to 90% viral knockdown in a vaccinia virus model, laying the…
Seek Labs Vice President of Research, Dr. Anindita Roy, Honored with 2025 Women Tech Council Rising Star Award October 6, 2025 Seek Labs is proud to announce our Vice President of Research, Dr. Anindita “Annie” Roy, has been selected as the Rising Star Award recipient by the Women Tech Council as part of the 2025…
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV) September 24, 2025 Salt Lake City, UT (Business Wire) – Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, announced today that it has joined two federally supported…
Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ to Advance Development of a Pan-Target, Programmable Therapeutic September 9, 2025 Salt Lake City, UT (Business Wire) – Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the inclusion of Foot-and-Mouth Disease (FMD) in its BioSeeker™ Global…
Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform Built in a matter of months, Seek Labs’ functional investigational prototype delivers point-of-care Mycobacterium tuberculosis detection without instrumentation, electricity, or lab infrastructure. August 13, 2025 View the SeekIt for MTB Poster here Salt Lake City, UT, August 13, 2025 (Business Wire) —…
Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™, Accelerating Therapeutic Discovery for Chikungunya, West Nile Virus, and Zika August 5, 2025 Salt Lake City, UT, August 5, 2025 (Business Wire) — Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the successful mapping…
Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains July 22, 2025 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the inclusion of veterinary…
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV) July 8, 2025 Read the Medium Article from our CEO, Jared Bauer, about the Urgent Need to Fight RSV Globally. Salt Lake City, UT (Business Wire) — Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and…
Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks June 23, 2025 Read the Medium Article from our CEO, Jared Bauer, about how Mapping Measles and other viruses can bring us closer to global readiness against existing and emerging diseases. SALT LAKE CITY, UT (Business Wire)…
Seek Labs Unveils BioSeeker™ Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions June 10, 2025 Read the Medium Article from our CEO, Jared Bauer, about how BioSeeker is redefining the fight against disease SALT LAKE CITY, UT, June 10, 2025 (Business Wire) – Seek…
Stay connected
Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.